Your Source for Venture Capital and Private Equity Financings

RxRevu Closes $7M in Series B Funding

DENVER, CO, RxRevu has closed its Series B funding round, raising $7 million.
RxRevu, an industry leader in Prescription Decision Support, has closed its Series B funding round, raising $7 million, bringing the total investment in the company to $28 million.

The investment round was led by JAZZ Venture Partners, with additional investments from existing strategic health system partners.

RxRevu is on a mission to improve healthcare by providing accurate, patient-specific coverage and cost data at the point-of-care. RxRevu's solutions help physicians quickly and easily find affordable care options specific to a patient's health and financial needs. RxRevu's solutions also enable health systems to manage and measure clinician's performance and variability.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors